Merck & Co Inc
MRK
NYSE
Pharmaceuticals
$148.99
USD
-3.21 (-2.11%)
At close: Aug 20, 2026, 4:00 PM EDT
Market Cap $329.55B
Volume 16.0M
Price Target
$141.00 – $179.00
USD
The 5 analysts offering 1-year price forecasts have a max estimate of $179.00 and a min estimate of $141.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$152.60
+$14.2 vs prior
Implied Upside
+2.4%
+9.5% vs prior
Analyst Covering
5
Unchanged vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$6.60 Gap
Median $146.00 vs avg $152.60 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
5 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
5 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Terence Flynn | Morgan Stanley | Buy | Upgraded | 1 day ago | Plus | Plus | Plus |
Vamil Divan | Guggenheim | Buy | Maintained | 2 weeks ago | Plus | Plus | Plus |
Evan David Seigerman | BMO Capital | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Louise Chen | Scotiabank | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Tim Anderson | B of A Securities | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
